Innovations & Investing
When the Algorithm Is Right
Artificial intelligence systems trained on large-scale imaging and clinical datasets now rival, and in some narrow domains exceed, human diagnostic...
Read more
Teaching the Immune System a Second Language
Cancer vaccines have reentered the policy and investment conversation with unusual persistence over the past two weeks, following reporting on...
Read more
A Quiet Revolution in the Margin: How Device Partnerships Are Rewiring Postoperative Monitoring
What began as discrete point solutions — a pulse oximeter here, a hemodynamic sensor there — is becoming a latticework...
Read more
The Pap Smear’s Successor Problem
HPV and cervical cancer screening innovation has re-entered the clinical and investment spotlight over the past two weeks as new...
Read more
The Physical Exam Is Becoming Software
Digital and remote health technologies — particularly AI-enhanced diagnostic tools such as software-assisted stethoscopes, camera-based vital sign systems, and algorithmic...
Read more
5 Fast Prototyping Paths for Regulated Medical Tech
Fast prototyping choices matter in regulated medical technology. A closer look at 5 paths teams consider when balancing speed, risk,...
Read more
Personalized Medicine Is No Longer Personal It’s Infrastructural
The genetic test result now travels faster than the referral it disrupts. Search and social-media discourse over the past two...
Read more
Cyber Risk Is Now a Core Procurement Metric — Expanded Analysis
Cybersecurity risk in healthcare has shifted from a technical concern to a core operational and procurement variable. Health system leaders...
Read more
Wearables Are Becoming Clinical Instruments. AI Is the Engine.
A decade ago, a smartwatch was a pedometer with ambitions. Today, wearables are producing physiologic traces that clinicians recognize as...
Read more
Why Investors Now Care About Patient Experience
Investor interest in healthcare increasingly tracks patient experience and retention rather than raw utilization growth. This shift was evident across...
Read more
The Retrieval Turn: RAG, LLMs, and the Next Generation of Clinical Generative AI
The core problem: language models are persuasive even when they are guessing Large language models excel at producing coherent text...
Read more
Digital Therapeutics Regulatory Pathways: Navigating Reimbursement, Validation, and Privacy
A single download can transform care delivery. When the U.S. Food and Drug Administration cleared Pear Therapeutics’ Somryst application—an app...
Read more
Glucagon-Like Peptide–Based Therapies and Longevity: Clinical Implications from Emerging Evidence
Glucagon-like peptide–based therapies are increasingly used for weight management and glycemic control, but their potential impact on long-term survival remains uncertain. The clinical question addressed in this report is whether treatment with glucagon-like peptide receptor agonists is associated with reductions in all-cause mortality and age-related morbidity beyond their established metabolic effects. This question matters because these agents are now prescribed across broad patient populations, including individuals without diabetes, and long-term exposure may influence cardiovascular, oncologic, and neurodegenerative outcomes. Understanding whether...
Read more